DECISION Trial Misses Primary Endpoint as Pooled Meta-Analysis of 9,013 Patients Finds Digitalis Cuts Heart Failure Events 15 Percent
Low-dose digoxin failed its primary endpoint in 1,001 Dutch heart-failure patients, but a JAMA meta-analysis of DECISION, DIGIT-HF and the 1997 DIG trial published the same day finds digitalis cuts the combined risk of cardiovascular death or first worsening event by 15 percent.
7 min read6 sources